(2016). Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure. BMJ Open. http://doi.org/10.1136/bmjopen-2016-014010.
(2016). The healthcare costs of heart failure during the last five years of life: A retrospective cohort study. Int J Cardiol. http://doi.org/10.1016/j.ijcard.2016.09.021.
(2017). Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model. Health Technol Assess. http://doi.org/10.3310/hta21400.